暂无简介。

入排标准

•- History of anaphylaxis, serious vaccine reactions, hypersensitivity to vaccine viral proteins or excipients
•- Administration of adjuvanted influenza vaccine or suspected influenza disease within 3 month prior to study start
•- Administration of any other vaccines within 4 weeks prior to enrollment expect for seasonal influenza vaccines within 1 week
•- History of progressive or severe neurological disorders

A Multi-center, Randomized, Single-blind, Dose-Ranging Study to Evaluate Immunogenicity, Safety and Tolerability of Different Doses of Adjuvanted Cell-Derived, Inactivated Novel Swine Origin A/H1N1 Monovalent Subunit Influenza Virus Vaccine in Healthy Japanese Pediatric Subjects

试验速览